Using nonlinear mathematical modeling and imaging results, as well as analysis of histological, immunohistochemical, and laboratory data, we identified key factors—such as tumor origin, treatment history, CK7 status, and tumor markers—that can help predict receptor status even without imaging. Here, KRT7 is linked to neoplasm.